Frohlich Tom 4
4 · Jade Biosciences, Inc. · Filed May 19, 2025
Insider Transaction Report
Form 4
Frohlich Tom
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2025-05-16$7.40/sh+6,000$44,400→ 6,000 total
4 · Jade Biosciences, Inc. · Filed May 19, 2025
Common Stock